Company Data
NRX Pharmaceuticals Inc.
Ticker
NRXP
Current Price
$3.54 12.74%
Market Cap
$33.9M
Price Target
Refer to Report
Volume
275.8K
52wk Range
$2.21 - $12
Overview
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.